Bleepa achieves CE Mark - Raising the bar for medical communication platforms

Philipp Prince Appointed as Non-Executive Director

15/07/20

Feedback Medical Feedback PLC

London, 15 July 2020:  Feedback plc (AIM: FDBK, “Feedback” or the “Company”) announces the appointment of Philipp Prince as a new Independent Non-Executive Director, effective immediately.

 

Philipp is a chartered accountant with extensive experience in senior finance roles in both private and listed technology companies. He runs his own financial consultancy business, is a board adviser at Overmore Limited, a marketing technology firm, and recently joined BCB Group Holdings Limited, a financial services challenger, as its non-board CFO.

 

He was previously the CFO of Defenx plc, an AIM-listed mobile cyber security company, where he managed the IPO process, fundraising and investor relations and Interim CFO at Enecsys plc, a private equity backed solar micro-inverter developer. For over 20 years, Philipp worked at BDO LLP, where he was a corporate finance partner from 2002-2013.

 

Rory Shaw, Chairman of Feedback, commented: “Philipp has strong experience within the technology sector, especially fundraising, capital markets and M&A. His input will be invaluable as we look to deliver shareholder value with the rollout of Bleepa to the NHS and other healthcare providers.”

 

Philipp Prince added: “Feedback is a great company. Even before the current Coronavirus pandemic, it was clear that Feedback’s flagship Bleepa product had great potential in solving communication and patient confidentiality issues within the healthcare sector. I am pleased to have joined the Board having recently participated in the placing. I look forward to working with the management team as we focus on delivering the group’s strategic vision.”

 

The following information is disclosed pursuant to rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies: 

Full name: Philipp Nicholas Andre Martin Prince
Age: 51
Shareholding in Feedback: 2,500,000 ordinary shares (equivalent to 0.23 per cent. of the Company’s issued share capital)
Current directorships held: None
Directorships held in the previous 5 years: Defenx Limited (previously Defenx plc)